A nurse shows the packaging of the Sputnik M vaccine. File photoMOSCOW, Jan 18More than half of the participants in the coronavirus vaccine study for adolescents have already received the first component, according to the website of the Mayor of Moscow, citing Ismail Osmanov, chief pediatrician of the capital, head physician of the Z. A. Bashlyaeva Children's City Clinical Hospital. «Today, half of the planned work has been completed — more than 1,500 adolescents were vaccinated with the first component, more than 1,200 of them — both the first and second. All this time, the guys keep a diary of well-being in a mobile application, and doctors monitor their condition … Preliminary results allow us to conclude that the vaccine is safe, «Osmanov is quoted as saying in the message. He added that at the moment no serious adverse reactions to the vaccine have been recorded in any vaccinated person, only in isolated cases there was a slight increase in temperature, fatigue, and pain at the injection site. It is emphasized that a total of three thousand will take part in the study volunteers. Of these, 2,400 people will receive the vaccine, and 600 people will receive a placebo. The distribution of participants in one group or another will happen randomly. Neither adolescents, nor parents, nor a doctor will know which group the participant will fall into. On November 24, the Ministry of Health of Russia registered the first domestic vaccine for adolescents aged 12-17, Gam-COVID-Vak M (Sputnik M). Assistant Minister of Health Alexei Kuznetsov told RIA Novosti earlier that vaccination of adolescents is voluntary, it will be carried out with the consent of parents or legal representatives. The director of the Gamaleya Center, Alexander Gintsburg, told RIA Novosti that a vaccine against coronavirus for adolescents is expected to enter the civil circulation this week. 12:40Infographics»Sputnik M»: the main thing about the teenage vaccine against COVID-19InfographicView
